ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York
ImageneBio, Inc., a clinical-stage biotech company specializing in immunological, autoimmune, and inflammatory disease therapeutics, announced that CEO Kristin Yarema will present at the Jefferies Global Healthcare Conference in New York on June 4, 2026. The company is advancing its lead program IMG-007 through Phase 2b trials for atopic dermatitis…